| Product Code: ETC13230533 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Angioedema Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Angioedema Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 North America Angioedema Market - Industry Life Cycle |
3.4 North America Angioedema Market - Porter's Five Forces |
3.5 North America Angioedema Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.8 North America Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 North America Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.10 North America Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.11 North America Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 North America Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Angioedema Market Trends |
6 North America Angioedema Market, 2021 - 2031 |
6.1 North America Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Angioedema Market, Revenues & Volume, By Solid Dosage Form, 2021 - 2031 |
6.1.3 North America Angioedema Market, Revenues & Volume, By Liquid Dosage Form, 2021 - 2031 |
6.2 North America Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Angioedema Market, Revenues & Volume, By Parenteral Route, 2021 - 2031 |
6.2.3 North America Angioedema Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.2.4 North America Angioedema Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.2.5 North America Angioedema Market, Revenues & Volume, By Oral Route, 2021 - 2031 |
6.3 North America Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Angioedema Market, Revenues & Volume, By Acquired Angioedema, 2021 - 2031 |
6.3.3 North America Angioedema Market, Revenues & Volume, By Idiopathic Angioedema, 2021 - 2031 |
6.3.4 North America Angioedema Market, Revenues & Volume, By Allergic Angioedema, 2021 - 2031 |
6.3.5 North America Angioedema Market, Revenues & Volume, By Drug-Induced Angioedema, 2021 - 2031 |
6.3.6 North America Angioedema Market, Revenues & Volume, By Hereditary Angioedema, 2021 - 2031 |
6.4 North America Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Angioedema Market, Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021 - 2031 |
6.4.3 North America Angioedema Market, Revenues & Volume, By Antihistamine, 2021 - 2031 |
6.4.4 North America Angioedema Market, Revenues & Volume, By Corticosteroids, 2021 - 2031 |
6.4.5 North America Angioedema Market, Revenues & Volume, By Glucocorticoids, 2021 - 2031 |
6.4.6 North America Angioedema Market, Revenues & Volume, By Adrenaline Injection, 2021 - 2031 |
6.4.7 North America Angioedema Market, Revenues & Volume, By Hereditary Angioedema Drug Class, 2021 - 2031 |
6.4.8 North America Angioedema Market, Revenues & Volume, By C1 Esterase Inhibitor, 2021 - 2031 |
6.4.9 North America Angioedema Market, Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021 - 2031 |
6.5 North America Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Angioedema Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.5.3 North America Angioedema Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.5.4 North America Angioedema Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.6 North America Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Angioedema Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 North America Angioedema Market, Revenues & Volume, By Homecare Settings, 2021 - 2031 |
6.6.4 North America Angioedema Market, Revenues & Volume, By Clinics, 2021 - 2031 |
7 North America Angioedema Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Angioedema Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
7.3.1 United States (US) Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
7.3.2 Canada Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
7.3.3 Rest of North America Angioedema Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
7.4 North America Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.1 United States (US) Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.2 Canada Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.3 Rest of North America Angioedema Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 North America Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
7.5.1 United States (US) Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
7.5.2 Canada Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
7.5.3 Rest of North America Angioedema Market, Revenues & Volume, By Therapy, 2021 - 2031 |
7.6 North America Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.1 United States (US) Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.2 Canada Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.3 Rest of North America Angioedema Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7 North America Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.7.1 United States (US) Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.7.2 Canada Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.7.3 Rest of North America Angioedema Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 North America Angioedema Market Key Performance Indicators |
9 North America Angioedema Market - Export/Import By Countries Assessment |
10 North America Angioedema Market - Opportunity Assessment |
10.1 North America Angioedema Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
10.4 North America Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.5 North America Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
10.6 North America Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.7 North America Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
11 North America Angioedema Market - Competitive Landscape |
11.1 North America Angioedema Market Revenue Share, By Companies, 2022 |
11.2 North America Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here